ArticleGels (Basel, Switzerland)2025
Swelling, Serosal Adhesion, Protein Adsorption, and Biocompatibility of Pectin-TEOS Gels.
Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The objective of this study was to develop a pectin-tetraethoxysilane (TEOS) hybrid gel with improved functional properties and biocompatibility. The sol-gel process was used to create pectin-TEOS hydrogels containing 0.75, 1.00, 1.25, and 1.50 M TEOS, which were labeled AP-T0.75, AP-T1.00, AP-T1.25, and AP-T1.50. The pectin-TEOS hydrogel AP-T1.50 exhibited a hardness of 631 kPa, a Young's modulus of 1588 kPa, and an elasticity of 1.95 mm. The degree of swelling decreased as the TEOS content increased. The pectin-TEOS hydrogel AP-T1.25 exhibited the highest strength of adhesion to serosa of 60.6 mN. Serum protein and bovine serum albumin (BSA) adsorption by pectin-TEOS gels was recorded in the range of 2-43 µg/mg after 6 h of incubation at pH 5.0, 7.4, and 8.0. Pectin-TEOS gels demonstrated low rates of hemolysis and complement activation. Leukocyte adhesion on the surface of pectin-TEOS gels depends on TEOS content. Consequently, the mechanical characteristics, serosal adherence, and biocompatibility of pectin-TEOS gel position it as a strong contender for the advancement of smart biomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.